142 träffarwomen's health

Karolinska Institutet - English

Fluoride in drinking water is associated with impaired childhood cognition7.3.2025 15:30:00 CET | Karolinska Institutet - English | Pressmeddelande

Elevated concentrations of fluoride can occur in well water, and in some countries, it is added to drinking water to counteract caries in the population. A study from Karolinska Institutet in Sweden now supports a few previous studies indicating that exposure to fluoride during the fetal stage or early childhood may impair cognition in children. The study is published in the journal Environmental Health Perspectives.
news aktuell GmbH

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal24.2.2025 15:59:57 CET | news aktuell GmbH | Press Release

Aachen, Germany & Toronto, Canada, 24 February 2025 – Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, non-opioid pain patch indicated for the management of neuropathic pain.
Karolinska Institutet - English

New study paves way for immunotherapies tailored for childhood cancers20.1.2025 17:00:00 CET | Karolinska Institutet - English | Pressmeddelande

Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.
news aktuell GmbH

Pioneering women set the stage for Slush at the INNOVEIT Conference in Helsinki5.11.2024 09:55:00 CET | news aktuell GmbH | Press Release

The European Institute of Innovation and Technology (EIT) invites you to celebrate women entrepreneurs driving innovation and investment in Europe. The EIT Community will be hosting the INNOVEIT Conference which will feature industry leaders like Inga Grieger, Katarzyna Piasecki and Laura Wirsztel. A pitch session will showcase pioneering women-led ventures shaping the future of technology. Exclusive insights: Conference attendees will gain access to the latest research findings from the study “Women founders in European deep tech startups” by the initiative EIT Supernovas, revealing women’s impact in deep tech and the launch of the new Data Room which enhances visibility for women-led startups and scaleups by connecting them with potential investors.
Karolinska Institutet - English

Perineal cut reduces the risk of serious birth injury18.6.2024 13:00:00 CEST | Karolinska Institutet - English | Press Release

In first-time mothers requiring vacuum-assisted delivery, a lateral episiotomy (angled cut) in the tissue between the vaginal and anal opening more than halves the risk of obstetric anal sphincter injury, a severe form of perineal trauma between the vulva and anus. This according to a randomised clinical study led by researchers at Karolinska Institutet and Stockholm’s Danderyd Hospital, the results of which are published in The BMJ.
Karolinska Institutet - English

New doping test can reveal more cheating female athletes11.6.2024 13:00:00 CEST | Karolinska Institutet - English | Press Release

Roughly three times as many male athletes are banned for doping as female. A new doctoral thesis from Karolinska Institutet shows that one possible reason for this is that the doping tests in use fail to take account of women’s varying hormone profile. Instead, an alternative is proposed that includes a blood test and a limit value that allows doping tests for both elite athletes and casual sportspersons.
news aktuell GmbH

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | news aktuell GmbH | Press Release

The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.
  • 1
  • 2
  • 3
  • 4
  • 5
  • Sista
  • >>
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye